1 year return (CAGR)
52.52%
CTi Biopharma Corp Exchange (NASDAQ, USD)
CTIC
-
0.00 (0.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
93.74%
5 year return (CAGR)
13.15%
10 year return (CAGR)
-3.29%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.20B
Price/Sales
15.82
Ent value
1.31B
Price/Book
-
Div yield
-
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
101.00
EPS growth
-6.19%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 9.09 |
| Daily high | 9.09 |
| Daily low | 9.09 |
| Daily Volume | 0K |
| 1y analyst estimate | 10.37 |
| Beta | 0.83 |
| EPS (TTM) | -0.59 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| CTIC | S&P500 | |
| Current price drop from All-time high | -100.00% | -9.69% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 29 Sep 2020 | 9 Mar 2009 |
| Avg drop from high | -89.90% | -10.68% |
| Avg time to new high | 169 days | 12 days |
| Max time to new high | 5700 days | 1805 days |
News
No items found